Licensed subcutaneous infusion therapies in advanced Parkinson’s disease: an indirect treatment comparison and cost-minimisation analysis

media

posted on 2025-07-10, 07:37 authored by Adis journals on behalf of:, Marc Vérin, Ángel Sesar, Bharat Amlani, Smith, Niall, Konstantinos Kipentzoglou, Stephen Montgomery, Alice Reading, Andrei Karlsson, Anna Willis, Andrew J. Lees

There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

apomorphine continuous dopaminergic stimulation device-aided therapy foslevodopa-foscarbidopa Parkinson's disease subcutaneous infusions

Licence

CC BY-NC 4.0

Licensed subcutaneous infusion therapies in advanced Parkinson’s disease: an indirect treatment comparison and cost-minimisation analysis

History

Usage metrics

Categories

Keywords

Licence

Exports